Will drugs companies follow EU agency from London to Amsterdam?

16 May 2019 - Amid the bustling skyscrapers of London’s Canary Wharf, one building stands silent and shuttered — a ...

Read more →

EMA begins search for next Executive Director

14 May 2019 - As Guido Rasi wraps up his second five-year term as the executive director of the European ...

Read more →

Two additional countries to benefit from EU-US mutual recognition agreement for inspections

30 April 2019 - In April 2019, the US FDA confirmed the capability of two additional European Union Member States ...

Read more →

Department of Health and Social Care seeks new Chair to lead NICE Board

16 April 2019 - Applications must be received by midday on 7 May 2019. ...

Read more →

Institute for Clinical and Economic Review Appoints Dr. Pamela Bradt as Chief Scientific Officer

2 April 2019 - The Institute for Clinical and Economic Review has announced the appointment of Pamela Bradt as the organization's ...

Read more →

Senate panel to hear from pharmacy middlemen on drug prices

21 March 2019 - The Senate Finance Committee said Thursday that it has secured commitments from executives of five major ...

Read more →

Institute for Clinical and Economic Review appoints new members to each of its three independent evidence appraisal councils

18 March 2019 - New members bring expertise in broad range of perspectives, including patient advocacy, health policy, economics, and clinical ...

Read more →

Cancer Institute's Sharpless tapped as acting chief of FDA

12 March 2019 - Ned Sharpless, the director of the National Cancer Institute, will be named temporary chief of the ...

Read more →

Donald Trump just lost his most popular bureaucrat

6 March 2019 - U.S. FDA Commissioner Scott Gottlieb is resigning and will leave the agency in a month, according to ...

Read more →

FDA chief tough on e-cigs steps down in surprise resignation

5 March 2019 - U.S. FDA Commissioner Scott Gottlieb said on Tuesday that he plans to step down next month, a ...

Read more →

CEOs hide as pressure on drug prices grows

30 January 2019 - This week, key committees in the House and Senate each held hearings on the rising cost ...

Read more →

The FDA has five weeks till money runs out for approving new drugs

16 January 2019 - The US FDA has roughly five weeks of funding left to review new drug applications during ...

Read more →

EMA to lose 25% of staff as hard Brexit approaches

14 January 2019 - As UK Prime Minister Theresa May’s Brexit deal is expected to be rejected Tuesday in a ...

Read more →

If the shutdown drags on at FDA, it will put anticipated new treatments in jeopardy

14 January 2019 - The government shutdown could soon jeopardise highly anticipated new drugs from Janssen, Sanofi, and Novartis for ...

Read more →

Cost recovery and Pharmaceutical Benefits Scheme process improvements information forums

14 January 2019 - The Department of Health will be hosting information forums in both Sydney and Melbourne regarding amendments ...

Read more →